ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

Senate Bill Would Authorize $1 Billion for NCI; House Version Senate Bill Would Authorize $1 Billion for NCI; House Version Approved

April 8, 1977

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped

February 22, 1985